About Febuxostat Febuxostat is used to lower hyperuricemia (high uric acid in the blood) in patients…
Tofacitinib is used alone or with other medications to treat rheumatoid arthritis (condition in which the body attacks its…
About Lusutrombopag Lusutrombopag is a medication that has been developed for certain conditions that lead to…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Ryzneuta® (Efbemalenograstim alfa-vuxw), sold under the brand name 亿立舒® in china, is a leukocyte growth factor used…
Tofidence® (Tocilizumab-bavi) sold under the brand name 施瑞立® in china, is a monoclonal antibody that binds to interlukin-6 receptors and…
Tofacitinib is used alone or with other medications to treat rheumatoid arthritis (condition in which the body attacks…
Upadacitinib is a medication used for the treatment of rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, and axial spondyloarthritis.Upadacitinib…
What is deucravacitinib used for? Deucravacitinib acts as a highly selective allosteric inhibitor of non-receptor tyrosine-protein kinase…
Eltrombopag is used to treat thrombocytopenia (a low blood platelet count) in adults and children with…
Medication management Oral administration Lesinurad is used in combination with xanthine oxidase inhibitors such as allopurinol Not recommended for patients…
Eltrombopag, sold under the brand name Elobopa, Promacta among others, is a medication used to treat…
Avatrombopag, sold under the brand name Phoavat, Doptelet, is a medication that used for certain conditions…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Copyright © 2021-2022 LienTeh.net All rights reserved.
